Faes Farma, S.a.

Neftalí García Domínguez

Gonzalo Hernández Herrero

Tania González García

Paloma Tato Cerdeiras

Roberto Olivera Tizne

Arturo Zazpe Arce

Pablo Morán Poladura

Yagamare Fall Diop

Reyes Corcóstegui Vivar

Bárbara Noverges Pedro

Ana Gonzalo Gorostiza

Fátima Garrido Fernández

Hugo Santalla García

Generosa Gómez Pácios

Tatiana María Suárez Cortés

Gonzalo Canal Mori

Víctor Rubio Royo

Álvaro Ganza González

Nicolas Tesson

Tania GONZÁLEZ GARCÍA

Tatiana María SUÁREZ CORTÉS

The invention relates to compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor.

Pyridopyrimidines as histamine H4-receptor inhibitors

The invention relates to an aqueous pharmaceutical composition comprising: The invention also relates to said compositions for use in the treatment and/or prevention of a disorder or disease susceptible to amelioration by antagonism of Hhistamine receptor and/or of a corticosteroid-responsive disease through nasal administration. The invention also relates to a process for preparing the aqueous pharmaceutical composition above mentioned.

Aqueous compositions comprising bilastine and mometasone

The invention relates to new intermediates in the synthesis of Eldecalcitol and to processes for the preparation of said intermediates and of Eldecalcitol.

Process and intermediates for the preparation of eldecalcitol

The invention relates to a process for preparing a compound of (III)   Compounds of formula (III) are key intermediates in the synthesis of Bilastine.

Process and intermediates for the preparation of bilastine

Growing community of inventors

Vizcaya, Spain

Neftalí García Domínguez